Abstract:Objective To analyze the clinical features and validation of Brighton criteria in Guillain-Barré syndrome (GBS) patients from southern China.Methods The clinical data of hospitalized GBS patients from 69 hospitals of 14 provinces/cities in southern China,the area south of the Huaihe River,between 1 January 2013 and 30 September 2016,were collected and analyzed retrospectively,and patients were classified according to the Brighton criteria of case definition,ranging from a highest (defined as level one) to a lowest (level four) level of diagnostic certainty.Results A total of 1 358 GBS patients were collected,including 51 cases with cranial nerve variants,157 with Miler-Fisher syndrome and 1 150 with classic GBS characterized by flaccid weakness of limbs.Among 1 150 cases of classic GBS,49.57％ (570/1 150) patients had antecedent events,with respiratory infection predominated (71.23％,406/570);83.74％ (963/1 150) presented limb weakness at onset,99.21％ (1 124/1 133) reached the peak within four weeks,with a score of 3.15 ± 1.16 for Hughes Disability Scale;99.56％ (1 128/1 133)developed bilateral weakness and 95.39％ (1 097/1 150) manifested flexia or hyporeflexia;the cerebrospinal fluid showed albuminocytologic dissociation in 80.58％ (772/958) patients whose lumbar puncture was performed;demyelinating GBS accounted for 48.14％ (401/833) and axonal subtype 18.01％ (150/833) respectively in patients with findings of nerve conduction studies available.According to Brighton criteria,the patients were stratified as level one in 44.09％ (507/1 150),level two in 45.74％ (526/1 150),level three in 7.57％ (87/1 150) and level four in 2.61％ (30/1 150) of all the patients,and 69.55％ (507/729),28.67％ (209/729),0％ (0/729) and 1.78％ (13/729),respectively in the patients with complete data (n =729).Conclusions In southern China,demyelinating subtype of GBS is predominant,whereas the proportion of axonal subtype is remarkably lower than that in northern China.The Brighton criteria have a high sensitivity for the diagnosis of GBS in southern China,and examination of cerebrospinal fluid and electrodiagnostic studies are necessary for stratified diagnosis.

The Investigation of S-100 Protein Level of Cerebrospinal Fluid and Blood Serum in Patients with Guillain-Barré Syndrome

High S100B Levels in Cerebrospinal Fluid and Peripheral Blood of Patients with Acute Basal Ganglial Hemorrhage Are Associated with Poor Outcome.

Expression of S100B Protein Levels in Serum and Cerebrospinal Fluid with Different Forms of Neuropsychiatric Systemic Lupus Erythematosus.

Elevated Serum Level of IL-2,IL-2Ab,IFN-α and IFN-α Antibody in GBS

Changes of serum levels of neopterin in patients with Guillain-Barre syndrome

Comparative Proteomics Analysis of Cerebrospinal Fluid of Patients with Guillain–Barré Syndrome

Proteomics Study of the Differential Expression Proteins in Serum Between Guillain-Barré Syndrome and Normal

Clinical features and validation of Brighton criteria in Guillain-Barré syndrome in southern China:retrospective analysis of 1358 hospitalized patients in four years

Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome

Alteration of Cystatin C Levels in Cerebrospinal Fluid of Patients with Guillain-Barré Syndrome by a Proteomical Approach

Application significance of S100B in the assessment of blood-brain barrier injury

Proteomic Identification of Potential Protein Markers in Cerebrospinal Fluid of GBS Patients

Identifying serum acute phase reactive protein expression in Guillain-Barré syndrome patients using proteomics technology

Correlation between blood-brain barrier permeability and clinical prognosis in patients with Guil-lain-Barre syndrome

Peripheral Blood and Cerebrospinal Fluid Cytokine Levels in Guillain Barré Syndrome: A Systematic Review and Meta-Analysis

Potential biomarkers identified by tandem mass tags based quantitative proteomics for diagnosis and classification of Guillain–Barré syndrome

Extensive cytokine biomarker analysis in serum of Guillain-Barré syndrome patients

The analysis of misdiagnosis and mismanagement of 145 patients with Guillain-Barré syndrome in the emergency department

Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome

Clinical Evaluation of Prognosis of Severe Posttraumatic Brain Injuries by Using S-100B

Altered Cerebrospinal Fluid Index of Prealbumin, Fibrinogen, and Haptoglobin in Patients with Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy.